Entropy Technologies LP lessened its position in Cabot Co. (NYSE:CBT - Free Report) by 58.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,595 shares of the specialty chemicals company's stock after selling 3,680 shares during the period. Entropy Technologies LP's holdings in Cabot were worth $237,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of CBT. First Citizens Bank & Trust Co. lifted its holdings in shares of Cabot by 2.1% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 5,426 shares of the specialty chemicals company's stock valued at $606,000 after buying an additional 109 shares during the last quarter. First Horizon Advisors Inc. lifted its stake in Cabot by 22.0% in the third quarter. First Horizon Advisors Inc. now owns 650 shares of the specialty chemicals company's stock valued at $73,000 after acquiring an additional 117 shares during the last quarter. GAMMA Investing LLC grew its position in Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock worth $123,000 after acquiring an additional 130 shares in the last quarter. CWM LLC increased its stake in shares of Cabot by 35.6% during the 3rd quarter. CWM LLC now owns 564 shares of the specialty chemicals company's stock worth $63,000 after purchasing an additional 148 shares during the last quarter. Finally, Moran Wealth Management LLC raised its holdings in shares of Cabot by 0.3% during the 3rd quarter. Moran Wealth Management LLC now owns 62,116 shares of the specialty chemicals company's stock valued at $6,943,000 after purchasing an additional 178 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities analysts have commented on the stock. StockNews.com downgraded shares of Cabot from a "buy" rating to a "hold" rating in a research report on Monday, February 10th. Mizuho cut their price objective on Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 7th. Finally, JPMorgan Chase & Co. lowered Cabot from a "neutral" rating to an "underweight" rating and set a $105.00 target price for the company. in a report on Monday, November 11th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, Cabot presently has a consensus rating of "Hold" and a consensus target price of $102.00.
Check Out Our Latest Stock Report on CBT
Cabot Stock Performance
Shares of Cabot stock traded up $0.68 during trading on Monday, reaching $86.53. The company's stock had a trading volume of 433,517 shares, compared to its average volume of 382,872. Cabot Co. has a one year low of $80.21 and a one year high of $117.46. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.36 and a current ratio of 2.00. The firm has a market cap of $4.69 billion, a price-to-earnings ratio of 11.49, a price-to-earnings-growth ratio of 0.76 and a beta of 1.19. The business's fifty day moving average price is $90.90 and its 200-day moving average price is $101.26.
Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. As a group, equities research analysts predict that Cabot Co. will post 7.57 earnings per share for the current year.
Cabot Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be issued a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date is Friday, February 28th. Cabot's dividend payout ratio (DPR) is presently 22.84%.
Cabot declared that its board has initiated a stock repurchase program on Tuesday, December 3rd that authorizes the company to buyback 10,000,000 outstanding shares. This buyback authorization authorizes the specialty chemicals company to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company's board believes its stock is undervalued.
Cabot Company Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Read More

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.